Shanghai MicroPort Endovascular MedTech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 664.25 million compared to CNY 510.16 million a year ago. Revenue was CNY 664.25 million compared to CNY 510.16 million a year ago.

Net income was CNY 300.88 million compared to CNY 249.98 million a year ago. Basic earnings per share from continuing operations was CNY 4.18 compared to CNY 3.47 a year ago. Diluted earnings per share from continuing operations was CNY 4.18 compared to CNY 3.47 a year ago.